Enveric Biosciences (ENVB) Gross Margin Growth (1y) (2015 - 2020)
Enveric Biosciences (ENVB) Gross Margin Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 228.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -475.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,672.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1,034.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 149.00 |
| Jun 30, 2020 | 40.00 |
| Mar 31, 2020 | -43.00 |
| Dec 31, 2019 | 54.00 |
| Sep 30, 2019 | -142.00 |
| Jun 30, 2019 | 6.00 |
| Mar 31, 2019 | -115.00 |
| Dec 31, 2018 | 72.00 |
| Sep 30, 2018 | 172.00 |
| Jun 30, 2018 | 255.00 |
| Mar 31, 2018 | -557.00 |
| Dec 31, 2017 | 112.00 |
| Sep 30, 2017 | 359.00 |
| Jun 30, 2017 | -368.00 |
| Mar 31, 2017 | 885.00 |
| Dec 31, 2016 | -2,721.00 |
| Sep 30, 2016 | -1,540.00 |
| Jun 30, 2016 | -231.00 |
| Mar 31, 2016 | -820.00 |
| Jun 30, 2015 | -205.00 |